Cases 11 - 16 of 16
Teijin Limited et al. v. Mylan Pharmaceuticals Inc.
as 1:2013cv01781
Plaintiff:
Teijin Limited , Teijin Pharma Limited and Takeda Pharmaceuticals USA, Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Counter_claimant:
Mylan Pharmaceuticals Inc.
Counter_defendant:
Takeda Pharmaceuticals USA, Inc. , Teijin Limited and Teijin Pharma Limited
Cause Of Action: 35 U.S.C. § 271
Teijin Limited et al. v. Dr. Reddy's Laboratories Ltd., et al.
as 1:2013cv01780
Plaintiff:
Teijin Limited , Teijin Pharma Limited and Takeda Pharmaceuticals USA, Inc.
Defendant:
Dr. Reddy's Laboratories Ltd. and Dr. Reddy's Laboratories Inc.
Cause Of Action: 35 U.S.C. § 271
Takeda Pharmaceuticals USA Inc. v. Amneal Pharmaceuticals LLC
as 1:2013cv01729
Plaintiff:
Takeda Pharmaceuticals USA Inc.
Defendant:
Amneal Pharmaceuticals LLC
Counter_claimant:
Amneal Pharmaceuticals LLC
Counter_defendant:
Takeda Pharmaceuticals USA Inc.
Cause Of Action: 35 U.S.C. § 271
Takeda Pharmaceuticals USA Inc. v. Par Pharmaceutical Companies Inc. et al
as 1:2013cv01524
Plaintiff:
Takeda Pharmaceuticals USA Inc.
Defendant:
Par Pharmaceutical Companies Inc. and Par Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
Takeda Pharmaceuticals USA Inc. v. Amneal Pharmaceuticals LLC
as 1:2013cv00493
Plaintiff:
Takeda Pharmaceuticals USA Inc.
Defendant:
Amneal Pharmaceuticals LLC
Counter_claimant:
Amneal Pharmaceuticals LLC
Counter_defendant:
Takeda Pharmaceuticals USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Sucampo AG et al v. Anchen Pharmaceuticals Inc. et al
as 1:2013cv00202
Plaintiff:
Sucampo AG , Sucampo Pharmaceuticals Inc. , R-Tech Ueno Ltd. and others
Defendant:
Anchen Pharmaceuticals Inc. , Par Pharmaceutical Inc. and Par Pharmaceutical Companies Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
